Hunter 4025 Advances with Medical Development

NLS diagnosis of Hunter 4025 scanner evolves as diagnostic methods evolve

The non-linear (NLS) diagnosis of the Hunter 4025 scanner is based on the new physics of quantum-entropy interactions, allowing maximum information on gravity, maturity and intensity of changes in the functioning of the human organism during medical examinations. In most cases, the application of this technique has principle implications for diagnosis and therefore for selection of appropriate treatment options. Therefore, the development of this method has become a major advance in diagnostic medicine. The Institute of Practical Psychophysics (IPP) started to design an NLS diagnostic system based on the research of Academician Svyatoslav Pavlovich Nesterov, who invented the underlying trigger sensor, using NLS diagnostic principles. The first systematic clinical trials were conducted from 1992 to 1999. At the beginning of the new century, the commercial manufacture of systems grew rapidly and the quality of the results obtained improved significantly.

Nonlinear diagnostic methods are still under development. The diagnostic approach has progressed so rapidly that the version of the system is updated every six months. The development of NLS technology is inseparable from the main problems of medicine - the cause of disease development, early diagnosis and the targeting of treatment efficiency. Despite the decline in mortality from cardiovascular disease (according to world statistics), the situation surrounding the "epidemic". 1" remains unfavorable. Continued growth in oncology and genetic diseases is being documented. In the modern world, protective, less invasive, bloodless procedures are combined with increasingly "radical" treatments. If we Considering that our civilization is technological, it is very likely that humanity will face new unknown diseases in the future. In this context, the development of diagnostic methods continues, and NLS research should be one of the most important.

Hunter 4025 continues to progress with medical development to become a better health product.